Cottone S, Fulantelli M A, Giuntini G, Mangano M T, Salemi S, Salerno L, Cerasola G
Centro Ipertensione, Cattedra di Fisiopatologia medica, Università, Palermo.
Recenti Prog Med. 1990 Sep;81(9):581-4.
We studied 45 hypertensive subjects to evaluate the usefulness of captopril test for identifying renal artery stenosis and small congenital kidney with the hypoplasia of the renal artery. In 18 hypertensives with hippuran renogram indicating renovascular disease, and in 27 essential hypertensives, the plasma renin activity (PRA) responses to an oral test dose (50 mg) of captopril were studied. A 60-minute post captopril PRA increase of 150% (or 400% if baseline PRA less than 3 ng/ml/h) was considered as positive. Digital venous angiography was performed in all cases. In the group of 18 subjects small congenital kidney in 7, and renal artery stenosis in 11 subjects were detected by angiography. Captopril test resulted negative in all patients with small congenital kidney (mean PRA% increase 58). The test identified 7 of the 11 renal artery stenoses (mean PRA% increase 477), sensitivity and specificity were 64% and 100% respectively. In the essential hypertensives-group, mean PRA% increase was 122; there were three false positives, and both sensitivity and specificity were 88%. This study demonstrates that the PRA response to oral captopril test is a useful screening test for distinguishing small congenital kidney from renal artery stenosis and for identifying the latter in hypertensive patients.
我们研究了45名高血压患者,以评估卡托普利试验在识别肾动脉狭窄和伴有肾动脉发育不全的先天性小肾脏方面的效用。在18名马尿酸盐肾图显示有肾血管疾病的高血压患者以及27名原发性高血压患者中,研究了口服试验剂量(50毫克)卡托普利后血浆肾素活性(PRA)的反应。卡托普利给药60分钟后PRA升高150%(如果基线PRA低于3纳克/毫升/小时则为400%)被视为阳性。所有病例均进行了数字静脉血管造影。在18名受试者组中,血管造影检测出7例先天性小肾脏,11例肾动脉狭窄。卡托普利试验在所有先天性小肾脏患者中结果均为阴性(PRA平均升高百分比为58)。该试验识别出了11例肾动脉狭窄中的7例(PRA平均升高百分比为477),敏感性和特异性分别为64%和100%。在原发性高血压患者组中,PRA平均升高百分比为122;有3例假阳性,敏感性和特异性均为88%。本研究表明,口服卡托普利试验的PRA反应是区分先天性小肾脏与肾动脉狭窄以及在高血压患者中识别后者的有用筛查试验。